Scleroderma and scleroderma-like syndromes.
genetic
morphea
scleroderma
scleroderma-like syndromes
syndromes of inflammatory/autoimmune
systemic sclerosis
toxic
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
06
12
2023
accepted:
03
05
2024
medline:
18
6
2024
pubmed:
18
6
2024
entrez:
18
6
2024
Statut:
epublish
Résumé
Systemic sclerosis is a systemic connective tissue disease whose main pathophysiological mechanism is a progressive fibrosis of internal organs and skin leading to thickening and induration. Blood vessels may also be involved. However, systemic scleroderma is not the only disease causing cutaneous sclerosis. There is a group of diseases that mimic scleroderma in their clinical presentation - these are scleroderma-like syndromes. A distinction can be made between syndromes of inflammatory/autoimmune, genetic, metabolic, toxic, drug-induced, occupational, paraneoplastic and syndromes caused by deposition disorders. In the following paper, we have reviewed the literature on scleroderma-like syndromes. We have outlined the factors predisposing to the development of each disease, its pathogenesis, clinical presentation, diagnostic and treatment process and the differences between each syndrome and systemic scleroderma.
Identifiants
pubmed: 38887288
doi: 10.3389/fimmu.2024.1351675
pmc: PMC11180720
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1351675Informations de copyright
Copyright © 2024 Romanowska-Próchnicka, Dziewit, Lesiak, Reich and Olesińska.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Australas J Dermatol. 2021 Aug;62(3):380-382
pubmed: 33769553
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Dermatology. 2022;238(3):579-586
pubmed: 34525472
Skin Appendage Disord. 2018 Apr;4(2):82-85
pubmed: 29765964
J Vasc Bras. 2019 Oct 30;18:e20190031
pubmed: 31723343
Medicina (Kaunas). 2021 Nov 20;57(11):
pubmed: 34833493
Am J Hematol. 2014 Feb;89(2):214-23
pubmed: 24532337
JAAD Case Rep. 2020 Aug 28;6(11):1141-1143
pubmed: 33134455
Indian J Sex Transm Dis AIDS. 2020 Jan-Jun;41(1):1-9
pubmed: 33062974
JAAD Case Rep. 2021 Sep 29;17:49-51
pubmed: 34703864
Int J Womens Dermatol. 2020 Dec 11;7(3):359-360
pubmed: 34222600
Qual Life Res. 2022 Oct;31(10):2995-3008
pubmed: 35653052
J Scleroderma Relat Disord. 2019 Jun;4(2):118-126
pubmed: 35382389
Curr Rheumatol Rep. 2017 Nov 4;19(12):74
pubmed: 29101481
Clin Dermatol. 2020 Mar - Apr;38(2):235-249
pubmed: 32513403
Biomolecules. 2020 Oct 12;10(10):
pubmed: 33053910
Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336
pubmed: 28712039
Transl Pediatr. 2017 Oct;6(4):300-312
pubmed: 29184811
Rheumatology (Oxford). 2012 Mar;51(3):557-61
pubmed: 22120602
J Am Acad Dermatol. 2003 Jan;48(1):55-60
pubmed: 12522371
Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101489
pubmed: 32147386
Blood Res. 2022 Apr 30;57(S1):27-31
pubmed: 35483922
Nat Rev Dis Primers. 2015 Apr 23;1:15002
pubmed: 27189141
Curr Treatm Opt Rheumatol. 2016 Mar;2(1):69-84
pubmed: 28473954
Semin Arthritis Rheum. 1986 Feb;15(3):200-12
pubmed: 3961509
Rheum Dis Clin North Am. 2018 Nov;44(4):585-603
pubmed: 30274625
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Allergol Int. 2019 Oct;68(4):437-439
pubmed: 30910631
J Dermatol. 2018 Aug;45(8):881-890
pubmed: 29235676
J Ultrason. 2021;20(83):e284-e290
pubmed: 33500796
Reumatologia. 2019;57(1):55-58
pubmed: 30858632
Allergol Int. 2022 Apr;71(2):163-168
pubmed: 34465533
J Family Med Prim Care. 2021 Feb;10(2):1037-1039
pubmed: 34041118
World J Clin Cases. 2021 Oct 16;9(29):8831-8838
pubmed: 34734063
Mol Genet Genomic Med. 2020 Jul;8(7):e1282
pubmed: 32406602
Ann Surg. 2019 Jan;269(1):30-36
pubmed: 30222598